J Clin Gastroenterol. 2006 Oct;40(9):776-83.
Summary of probiotic activities of Bifidobacterium lactis HN019.
Sanders ME.Dairy and Food Culture Technologies, 7119 S. Glencoe Ct, Centennial, CO 80122, USA. This email address is being protected from spambots. You need JavaScript enabled to view it.
The bacterium, Bifidobacterium lactis HN019, has been studied for a variety of traits important to its ability to function as a probiotic. Publications documenting identity, safety, antipathogenic effects, immune enhancement, and intestinal colonization are reviewed. Most studies documenting immune effects are short term in duration (< or =6 wk feeding periods), so longer term trials would be useful to determine to what extent effects are sustained. One year-long trial feeding both galacto-oligosaccharides and HN019 in children 1 to 3 years of age provided evidence for improved growth and reduction in infection incidence. HN019 is a well-characterized probiotic strain with documented probiotic effects of meaningful magnitude especially in the area of immune system modulation.
PMID: 17016131 [PubMed - indexed for MEDLINE]
Related Articles:
Mold Testing & Sanitizer:
ADVERTISEMENT
